| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |